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ABSTRACT  The biosynthesis of fibrinogen  increased  at least eightfold  in primary hepatocytes 
when  incubated  in  the  presence  of  monocyte/macrophage-derived  hepatocyte  stimulating 
factor (HSF). The large increase  in fibrinogen production is due to increased  availability of the 
mRNAs for the protein  since  cytodot analysis  of cellular  RNA showed a 10-12-fold  increase 
in each of the fibrinogen mRNAs.  Pulse-chase experiments showed that the time for fibrinogen 
synthesis,  assembly,  and secretion was 40-50 min for both control and stimulating conditions. 
This  indicates  that the  increased  production  was due  principally  to the  presence  of greater 
amounts of fibrinogen  mRNA rather than translation  or secretion-specific  events.  Three lines 
of evidence  indicate  that the  increase  in  fibrinogen  production  was due to  HSF effects  on 
transcription:  (a) analysis of cytoplasmic  levels of each  of the fibrinogen  mRNAs showed that 
all  three  increased  at the  same  rate and to the same  extent,  demonstrating that  HSF affects 
the three gene products coordinately;  (b)  Northern gel analysis of cytoplasmic  RNA isolated 
after  very  brief  exposures  to  HSF showed  increases  in  a  large  molecular  weight  fibrinogen 
RNA  precursor;  and  (c)  actinomycin  D  blocked  the  HSF-stimulated  increase  in  fibrinogen 
mRNA species.  Furthermore, experiments  in which protein  synthesis  was inhibited  by cyclo- 
heximide failed to inhibit the increase  in fibrinogen  mRNAs,  indicating new protein synthesis 
is not required for the HSF stimulation  of fibrinogen  mRNA. These  results are consistent with 
our hypothesis that HSF is exerting its control of fibrinogen at the level  of gene transcription. 
Fibrinogen is a complex glycoprotein whose subunit structure 
consists of three pairs of nonidentical polypeptide chains. The 
principle site of synthesis of the protein is in hepatic paren- 
chymal cells (1,  16). The biosynthesis of fibrinogen is under 
complex coordinated control since  its  production involves 
both transcription and processing of three different mRNAs 
( 19, 20) as well as a complicated translational assembly of the 
three different subunits (35, 36). Under normal circumstances 
the  fibrinogen genes appear to  be  constitutively regulated. 
However, during an acute inflammatory reaction the produc- 
tion of fibrinogen and of its mRNAs increases significantly 
(4,  12,  13). The molecular mechanisms responsible for these 
changes have not been determined. 
We and others have shown that human peripheral blood 
monocytes/macrophages and  murine and  human  myeloge- 
Abbreviations used in this paper: HSF, hepatocyte  stimulating  factor; 
IL- 1, interleukin-  1. 
nous  cell  lines  produce a  monokine that  we  have  named 
hepatocyte stimulating factor (HSF)  l (2,  8,  23,  25-28,  33). 
The HSF produced by all  of these cells  is due to de novo 
synthesis of a  25-30-kD protein (33,  34).  The synthesis of 
HSF in  macrophages is  controlled by the  plasmin-derived 
fragments of fibrin or fibrinogen (18,  25,  26).  Of particular 
interest to us was the observation that exposure of primary 
rat hepatocytes to HSF resulted in an increased production 
of fibrinogen  that  mimicked  that  reported  for  fibrinogen 
during an in vivo inflammatory reaction. 
In this paper, we have used highly purified HSF and pri- 
mary rat hepatocyte cultures to further explore the molecular 
events that regulate increases in fibrinogen production. We 
determined that  (a)  an  increase  in  fibrinogen  production 
(synthesis and  secretion) can  be  detected as  early  as  2  h 
although cells  require exposure for  12  h  to get a  maximal 
response, and  (b)  the time required for newly synthesized 
fibrinogen to be secreted is the same in both stimulated and 
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effects of HSF on mRNA levels provided the following infor- 
mation:  (a)  the addition  of actinomycin  D  to  hepatocytes 
exposed to HSF blocked the HSF-stimulated fibrinogen re- 
sponse, (b) cytoplasmic levels of fibrinogen mRNAs increase 
10-12-fold over control by a  12  h  exposure to HSF,  (c) all 
three fibrinogen mRNAs increased at the same rate and to 
the  same  extent,  (d)  Northern gel  analysis  of cytoplasmic 
RNA showed the presence of a large molecular weight species 
(presumably fibrinogen mRNA precursors) as early as 30 rain 
after HSF exposure, and (e) the addition of cycloheximide 1 
h  before adding HSF had no inhibitory effect on increasing 
cytoplasmic levels  of fibrinogen  mRNAs,  although  protein 
synthesis was completely inhibited. These data imply that the 
HSF signal affects fibrinogen synthesis principally at the RNA 
level. In this regard, the data are consistent with our hypothesis 
that HSF exerts its control of fibrinogen at the level of gene 
transcription. 
MATERIALS AND  METHODS 
Preparation of Antigens and Antibodies:  Rat fibrinogen was 
purified  to homogeneity  from rat plasma  (3). Rat  fibrinogen  antibody  was 
produced  in goats and made monospecific by affinity chromatography  using 
fibrinogen covalently linked to Sepharose as described previously (4, 19). 
Immunoassays: ELISA:  Fibrinogen concentration  in the hepatocyte 
medium was determined  using a quantitative  enzyme-linked immunoassay as 
previously described (14, 24). This assay system can detect  fibrinogen in the 
nanogram range. 
Immunoadsorption:  Fibrinogen was removed from hepatocyte me- 
dium by incubating in the presence of Sepharose 4B (Pharmacia Inc., Piseata- 
way, N  J) to which monospecific fibrinogen antibody had been covalently linked 
(3). Ordinarily  50 ~1 of the affinity resin was added per milliliter of medium 
and the slurry gently mixed at 4"C for 16 h. The resin was removed from the 
medium by centrifugation.  50 ~1 of the antibody  resin could bind 200 tzg of 
fibrinogen/ml. 
Hepatocytes:  Primary hepatocytes were prepared from male 200-300- 
g Sprague-Dawley rats  using the collagenase perfusion  procedure  originally 
described  by Seglen (29) with  several minor modifications  (23). Confluent 
monolayers were prepared by plating 0.5 ml of  a washed hepatocyte suspension 
(3.0 x  l0  s) on 35-mm tissue culture plates previously coated with fibronectin 
(50 ~g/ml) in sterile phosphate-buffered saline (PBS). When treated in this way 
the hepatocytes attach  and spread  to form a confluent  monolayer  in 4-8 h. 
Hepatocytes  were  cultured  in  Williams  Medium  E  lacking  arginine.  This 
medium was supplemented  with ornithine  (50 nM), insulin (100 mU), dexa- 
methasone  (50 nM), penicillin G (200 U/ml), streptomycin  sulfate (200 ~g/ 
ml),  and gentamycin  (60 ~g/ml).  Cells incubated  in this  medium could  be 
maintained  without  loss of metabolic  capability  for 48  h.  The  ceils were 
routinely incubated for only 24 h, after an overnight period of attachment  and 
spreading. 
Monocytes:  Human peripheral blood monocytes were obtained  from 
the University of Texas Medical School blood bank from anonymous donors. 
An equal volume of sterile Hank's basic salt solution  (HBSS) and heparin (5 
U/ml) was added  to buffy coat suspensions,  and 30 ml of this  mixture  was 
layered over  10 ml of Histopaque  (Sigma Chemical Co., St. Louis, MO) that 
had previously been placed in 50-ml sterile centrifuge tubes (Falcon Labware, 
Oxnard, CA). The tubes were centrifuged for 40 min at  1,600 g. Mononuclear 
leucocytes were collected from the interface and then washed three times using 
sterile HBSS. After the three washes with HBSS, the cells were resuspended in 
McCoy's 5A medium (Gibco Laboratories, Grand Island, NY) containing  5% 
fetal bovine serum.  Cells were counted  and plated  on 60-mm tissue culture 
plates at a density of 5 x  107 cells/ml followed by an incubation  period of 1 h. 
Nonadherent cells were removed by gently rinsing the plates twice with medium 
lacking fetal bovine  serum.  The purified  monocytes  which  represented  the 
adherent cells were incubated in serum-free McCoy's 5A medium for 24 h in a 
5%  CO2/95% air  tissue  culture  incubator.  The  conditioned  medium  was 
harvested from the cells after 24 h and served as the starting material for further 
purification. 
Preparation  of HSF-III:  The  monocyte  conditioned  medium  was 
dialyzed against 20 mM Tris/HCl pH 7.2 and chromatosraphed over a 2.5  x 
3 cm DEAE-cellulose column (DEAE  53 from Whatman Inc., Clifton, NJ); 
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dialyzed monocyte conditioned medium (HSF-I) was applied to the column at 
a flow rate of 20 ml/h, the column was then washed with  150 ml of 40 mM 
sodium chloride, 20 mM Tris/HCl pH 7.2, and the HSF was eluted from the 
column with  100 ml of 60 mM sodium  chloride, 20 mM Tris/HCl pH 7.2. 
This  pool  of monokines  (HSF-II)  was dialyzed  and  concentrated  using  a 
Prodicon apparatus  (Bio-Molecular Dynamics, Beaverton, OR). HSF was fur- 
ther purified by gel permeation  chromatography  using a TSK-3000  column 
(Alltech Associates, Inc., Deerfleld, IL) and a Waters high performance liquid 
chromatography  system (Waters  Associates, Millipore Corp.,  Milford,  MA) 
(33), and material  of 22-30  kD was collected. HSF purified in this way was 
~500-fold enriched over conditioned  medium and contained no interleukin- 1 
(IL-I) activity when tested by a thymocyte proliferation assay (33). 
RNA  Extraction  and Isolation:  Confluent  monolayers of hepato- 
cytes (100-mm  plates) were incubated  with  HSF (10-12  U/ml) for varying 
periods of time.  We have previously defined a  unit of HSF activity as that 
amount of HSF required to get a half-maximal fibrinogen synthesis response 
in primary  hepatocytes (23, 24). At the end of each time point the ceils were 
washed with ice cold PBS twice and then  scraped from the  plate and RNA 
extracted by the guanidine-HC1 procedure (6). 
Nick  Translation:  Nick  translation  of plasmids  containing  cDNA 
inserts for each of  the fibrinogen genes was done using a commercial translation 
kit from Bethesda Research Laboratories. These cDNA probes were a generous 
gift from Dr. Gerald  R. Crabtree (Stanford University). 32P-dCTP (3,000 Ci/ 
mmol; ICN K & K Laboratories, Inc., Plainview, NY) was used to label the 
cDNAs for each fibrinogen message. The specific radioactivity of each probe 
was 3.0 x  l0  s cpm/~g of plasmid DNA. 
Northern Analysis:  10 ~g of total cellular RNA was electrophoresed 
in agarose according to published  procedures  (15). After electrophoresis the 
RNA  was transferred  from the agarose gel to nitrocellulose  using standard 
methods (30). After an overnight transfer the nitrocellulose was dried in vacuo 
and heated to 80"C for 2 h. The denatured  RNA was then hybridized with a 
mixture of the three 32P-labeled fibrinogen cDNA probes. Usually 5-8 x  107 
cpm/probe was used in the hybridization assay. 
Cytodot Analysis:  The  procedure  followed for the cytodot  analysis 
was a modification  of that described by White and Bancroft (32). Confluent 
monolayers of hepatocytes on 35-mm tissue culture plates were scral~ed into 
ice cold  10  mM  Tris  buffer  (pH  7.0) containing  1 mM  EDTA  and 0.5% 
Nonidet P-40 (Shell Chemical Co., Houston, TX). The cells were homogenized 
and cell debris removed  by centrifugation  (10,000 g for 10  min).  An equal 
volume of 20 x  SSC/37%  formaldehyde (3:2) was added to the supernatant 
(20 x  SSC contains 0.15 M NaCI, 15 mM trisodium  citrate) and the mixture 
incubated at 60"C for 15 min. The RNA was serially diluted and applied to the 
nitrocellulose using the Schleicher & Schuell minifold (Schleicher & Schuell, 
Inc., Keene,  NH). The dot blots were baked, prehybridized,  hybridized, and 
washed as above except that 3 x  107 cpm/probe was used per assay. 
RESULTS 
Dose-Response Relationship of HSF 
and Fibrinogen 
We have previously shown that the amount of fibrinogen 
produced  by  primary  hepatocytes is  dependent  upon  the 
amount of monocyte conditioned medium added to the me- 
dium  of these cells  (25).  Fig.  1 shows  the  relative specific 
activity of dialyzed monocyte condition medium (HSF-I), the 
DEAE-cellulose  fractionated  material  (HSF-II),  and  the 
HPLC-fractionated material (HSF-III). The specific  activity 
of HSF-III is ~500-fold higher than that of HSF-I. HSF-III 
contained no IL-1 when measured by the thymocyte prolif- 
eration assay (data not shown). 
Effect of HSF on Fibrinogen Secretion 
The time required for fibrinogen synthesis was determined 
after addition of HSF  to confluent monolayers of primary 
hepatocytes.  Medium  was  harvested  at  varying times  and 
assayed for the presence of fibrinogen (Fig.  2A).  HSF pro- 
duced an increase in secreted fibrinogen within 3 h. Fibrino- 
gen concentrations increased for the next 15 h and remained 
elevated  thereafter.  Fibrinogen  production  by  control cells 100  C  o 
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FIGURE  1  Response of primary rat hepatocytes to increasing con- 
centrations of HSF. Increasing concentrations of HSF were added 
to confluent monolayers of hepatocytes.  Fibrinogen concentration 
in the medium was determined using an enzyme-linked quantitative 
immunoassay.  Medium  from  maximally stimulated  hepatocytes 
contained 13.28 #g of fibrinogen, and controls contained 1.28 .ug 
(13-fold stimulation).  (HSF I, II, III refer to different stages of purifi- 
cation.) 
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FIGURE 2  (A) Temporal response of fibrinogen secretion  to HSF. 
Primary  rat  hepatocytes were plated onto 35-mm  tissue culture 
plates. The cells were washed with warmed fresh  medium 16 h 
after plating and a maximal dose of HSF added (12 U) to triplicate 
sets of plates. Medium was removed at the times indicated and the 
concentration of fibrinogen determined. Results are shown from 
control hepatocytes  (O) and HSF-treated samples (IlL (B) Effect of 
HSF on  fibrinogen synthesis.  Primary  rat  hepatocytes  in  35-mm 
plates were pulsed with [3H]leucine (50/zCi/ml; specific radioactiv- 
ity 50 Ci/mmol) for 20 min before harvest at each indicated time 
point. After the radioactive pulse, the cells were washed with ice 
cold PBS and then lysed. The amount of radioactivity incorporated 
into fibrinogen was measured by immunoprecipitation using mon- 
ospecific antibodies bound to  Sepharose and then counting the 
complex in a scintillation spectrophotometer (LS 7000,  Beckman 
Instruments,  Inc., Palo Alto, CA). The ratio of labeled fibrinogen in 
HSF-treated and control is plotted against time of HSF exposure. 
also increased but to a lesser extent• The increase in fibrinogen 
secretion was due to synthesis of new fibrinogen (Fig.  2B). 
HSF-stimulated and control primary hepatocytes were pulsed 
with  [3H]leucine for  20  min  before  each  time  point.  The 
radioactivity offibrinogen was determined by immunoprecip- 
itation using  monospecific  antifibrinogen.  The  quantity of 
fibrinogen increased eightfold over control during the 24-h 
period as shown in Fig. 2 B. 
Cellular Transit Time for Fibrinogen during 
HSF Stimulation 
We determined whether HSF affected the time required for 
the delivery of fibrinogen to the extracellular space• Hepato- 
cytes were pulsed with [35S]methionine for  l0 rain, washed 
free of the radioactive label, and fresh warmed nonradioactive 
medium  added.  Samples were taken at  10-min intervals to 
determine  the  time  required  for  radioactive  fibrinogen  to 
appear in the medium. Radiolabeled fibrinogen first appeared 
at 40 min, indicating that the synthesis, assembly, and transit 
time through the cell (endoplasmic reticulum to Golgi appa- 
ratus to secretory  vesicle to plasma membrane) requires  35- 
45  min  (Fig.  3).  The  time  of appearance  of radiolabeled 
fibrinogen was essentially the same for control and the HSF- 
stimulated cells, indicating that the increased production of 
fibrinogen  caused  by  HSF  does  not  alter  the  intracellular 
transit time of fibrinogen. 
Length of Time Required To Get 
Maximal Stimulation 
The temporal events involved in HSF induction of fibdn- 
ogen synthesis  are unknown. To gain some insight, we mea- 
sured how  long the  hepatocytes  had  to  be  in  contact  with 
HSF to get a maximal response.  Hepatocytes were exposed to 
HSF for varying lengths of time (from 2-24 h). The amount 
of fibrinogen secreted into the medium by hepatocytes ex- 
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FIGURE 3  Cellular transit time for fibrinogen in HSF-stimulated and 
control cultures. Confluent cultures of rat hepatocytes were treated 
for 16 h with 12 U HSF. After incubation with HSF the cells were 
washed  with  warmed  fresh  medium  and  50  /+Ci  of  [3sS]- 
methionine (specific  radioactivity 3,000 Ci/mmol) added for a 10- 
min  pulse.  Cells were then quickly washed,  and warmed, fresh 
nonradioactivemedia  was added. Cell media was then removed at 
10-min intervals and fibrinogen antibody added. After an overnight 
incubation, Staphylococcus  protein A was added and the radioac- 
tivity of the entire antibody-antigen complex determined. 
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FIGURE  4  Fibrinogen production by hepatocytes after exposure to 
HSF  for varying times.  Triplicate  35-ram confluent  monolayers of 
primary hepatocytes were treated with  12 U/ml of HSF. At the end 
of  each  time  period  (2,  6,  9,  12,  and  20  h),  the  HSF-containing 
medium was removed and chased with fresh medium lacking HSF. 
For each time point, the two media (HSF and chase) were combined 
and the amount of fibrinogen determined. 
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Effect of actinomycin D on the production of fibrinogen. 
Confluent monolayers of hepatocytes were incubated in the pres- 
ence of 12  U/ml of HSF. At the time points indicated, actinomycin 
D  (2.5 pg/ml) was added and the incubation continued for a total 
of 24 h. The cell medium was then harvested and the concentration 
of fibrinogen determined. 
posed to HSF for different times is showfi in Fig. 4. The cells 
began to respond to HSF almost immediately. However, it 
required a continual presence of HSF for at least 12 h to elicit 
the maximum response. 
results indicate that under our experimental conditions acti- 
nomycin D does not affect protein synthesis. 
Cytodot Analysis for Fibrinogen Messages 
Experiments were performed to gain information on  the 
cytoplasmic levels of fibrinogen (messages) at various times 
after the addition of HSF. Total cytoplasmic RNA containing 
fibrinogen mRNA was assayed by cytodot analysis. The mes- 
sage for each fibrinogen chain increased during the first 12 h 
to  HSF exposure (Fig.  6).  Furthermore,  both  the  response 
time and the amount of each mRNA species increased in a 
coordinated fashion, suggesting a highly synchronized control 
of the synthesis or stabilization of these messages. The fold 
increase for each fibrinogen mRNA increased to a  level  12 
times that of the mRNA in control cultures. 
HSF Effects on Early Fibrinogen mRNA 
Syn thesis/Stabiliza Lion 
To examine the effects of HSF on RNA synthesis and/or 
stabilization, we extracted total cellular RNA at  15,  30,  60, 
and 90 min after the addition of 12 U  of HSF. The specific 
radioactivity of our cDNA probes was increased by pooling 
the nick-translated A,, Ba, and 3' probes. A higher molecular 
weight  hybridizing  band  was  detected  at  the  30-min  time 
point and  was even more apparent in  the  60- and  90-min 
samples (Fig.  7).  The larger molecular weight RNA species 
suggests an increase in transcription and/or a stabilization of 
the fibrinogen mRNA precursors. 
Effect of Actinomycin  D on HSF Stimulation 
We wished to determine if the  12  h  of HSF stimulation 
necessary for maximal increase in fibrinogen production was 
due to the transcription of new mRNAs. The antibiotic acti- 
nomycin D  was added to hepatocytes at varying times after 
the addition of HSF. The results shown in Fig. 5 indicate that 
the actinomycin D blocking of transcription also blocked the 
rise in fibrinogen synthesis. These fndings suggest  that new 
fibrinogen  mRNA  synthesis  is  required  for  the  increased 
production of fibrinogen under HSF stimulation. When acti- 
nomycin D  was added to  hepatocytes, fibrinogen synthesis 
was not inhibited,  but rather it was maintained at the same 
levels  as  that  before  the  addition  of the  antibiotic.  These 
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FIGURE  6  Cytoplasmic  RNA  analysis  using cDNA  probes  for  A~, 
B~, and 3' messages. Primary hepatocytes (1.5 x  106) were incubated 
with  HSF  (12  U/ml).  At  each  time  period  shown  the  cells  were 
washed with  cold  sterile PBS and  the cells  scraped and  homoge- 
nized as described  in Materials and Methods. The cell extract was 
diluted such  that the top row contains  1 /~g of RNA,  then serially 
diluted  1:2  for the wells  below. The  control  shown  is that  taken 
from a 24-h  sample and  probed with the A~ cDNA.  The  B  e and ~, 
controls  were  indistinguishable  from  the  Aa  control  and  are  not 
shown in the figure.  The fold  increase was determined by quanti- 
tative scans of the cytodot films. FIGURE  7  Northern analysis of hepatocyte RNA after incubation 
with  HSF. Twenty  100-mm  tissue  culture  plates containing con- 
fluent monolayers of hepatocytes were incubated with 12 U/ml of 
HSF. At each of the time periods indicated the RNA was extracted 
from four plates as described in Materials and Methods. The total 
cellular RNA was separated by agarose-formaldehyde  gel electro- 
phoresis  and transferred  to  nitrocellulose filters.  All three cDNA 
probes were combined and used to identify the larger molecular 
weight RNA species. Arrows on the left indicate the position of the 
28S and 18S ribosomal RNA. 
Effects of Cycloheximide  on  HSF-stimulated 
mRNA  Increases 
To determine whether the increase in flbrinogen mRNAs 
after the addition of HSF requires the synthesis of a protein, 
we performed the following experiment. Hepatocyte cultures 
were treated with HSF in the presence and absence of cyclo- 
heximide (2 ~g/ml). After a  20-h incubation,  RNA was ex- 
tracted and dot analysis performed. The results of the exper- 
iment shown in Fig. 8 indicate that the presence of cyclohex- 
imide in the medium did not diminish the stimulatory signal 
of HSF for fibrinogen mRNAs. Medium taken from cell plates 
treated with cycloheximide contained no detectable flbrino- 
gen, indicating the synthesis of this protein had been blocked 
(data not shown).  The results of these experiments indicate 
that the  stimulatory action  of HSF is  not  dependent  upon 
protein synthesis for increasing the three fibrinogen mRNAs 
and  strongly  suggests that  HSF  is  acting  through  a  direct 
pathway. 
DISCUSSION 
In these studies we have examined the regulation of fibrinogen 
biosynthesis by HSF in isolated hepatocytes and have shown 
that HSF exerts rapid and specific effects on the concentration 
of mRNA for each  of the  three different fibrinogen genes. 
Within  15-30  min  after  HSF  exposure,  larger  molecular 
weight RNA species that hybridize with cDNAs made from 
fully processed fibrinogen mRNAs are present. This demon- 
strates that  these  species are  fibrinogen  mRNA precursors. 
The  results presented  here also  show that  there  is  a  time- 
dependent increase in the cytoplasmic mRNA of fibrinogen 
FIGURE 8  Effects  of cycloheximide on the HSF stimulation of fi- 
brinogen mRNA. Confluent monolayers of hepatocytes  in 35-mm 
plates were incubated with 12 U of HSF and/or 2/zg/ml of cyclo- 
heximide, a, control; b, +HSF; c, +cycloheximide;  d, +HSF +cyclo- 
heximide. Cycloheximide was added  I  h  before the addition of 
HSF, and  the  incubation continued for  20  h.  Dot  blots  of the 
extracted  RNAs were  hybridized  with  all  three  nick-translated 
cDNA  probes.  1 /~g of  RNA  in  the top well was diluted  1:2  as 
described.  Culture medium from all samples was assayed for the 
presence of fibrinogen. Samples containing cycloheximide showed 
no detectable secreted fibrinogen (data not shown). 
that  correlates precisely with  an  increase  in  the  synthesis, 
assembly, and secretion of fully functional fibrinogen. 
The effects of HSF on fibrinogen translation occur concom- 
itantly  with  increased  fibrinogen  mRNAs;  however,  when 
actinomycin D is added, the rise in fibrinogen synthesis ceases. 
Since it is well established that actinomycin D  inhibits gene 
transcription (9), our findings are consistent with the hypoth- 
esis that the principal site of HSF action is at the transcrip- 
tional level and that the increases in fibrinogen concentrations 
are  due  to  increased  amounts  of fibrinogen  mRNAs.  It is 
unlikely that  HSF  is  exerting  its  stimulatory influence  on 
protein translation in general since (a) the synthesis of many 
of the hepatocyte-derived proteins are unaltered as a result of 
exposure to HSF (data not shown) and (b) hepatocyte albu- 
min synthesis decreases in the presence of HSF (27,  33). 
It is well recognized that  monocytes/macrophages and  a 
variety of established  cells lines  of the  myelogenous series 
produce IL-1, a potent monokine with thymocyte prolifera- 
tion activity. Although several reports have indicated that IL- 
l  stimulates fibrinogen synthesis (10,  I l, 21),  we could not 
duplicate these results.  In experiments using IL-1  from two 
sources  2 and in concentrations as high as 104 U, we observed 
no increase in fibrinogen production over control (33).  Fur- 
thermore, the HSF-III used in our studies had no IL-1 activity. 
Thus, the results shown are directly attributable to 25-30-kD 
proteins that we have previously described and have named 
HSF (22). 
Although hepatocytes required exposure to HSF for  12 h 
before  reaching  a  maximal  response,  a  clearly  detectable 
increase in mRNA precursors occurred as early as  15  min. 
This rapid response in  mRNA precursors is similar to that 
2  Human IL-I was purchased from Genzyme Corp., Boston, MA. 
Cloned mouse IL-I was a generous girl from Dr. Peter Lomedico of 
Hoffmann-La Roche, Inc., Nutley, NJ. 
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transcriptional activity of the prolactin gene (17). The HSF- 
induced increase in fibrinogen mRNA levels does not require 
protein synthesis and differs from that of another hepatically 
derived protein induced during inflammation (al acid glyco- 
protein) (31). This finding suggests that there may be several 
pathways involved in the induction of different plasma pro- 
teins during an acute inflammatory response. 
We have shown here that a hormone-like polypeptide, HSF, 
made by monocytes acts directly on hepatocytes to increase 
fibrinogen  synthesis.  This marked increase in  fibrinogen is 
directly related to the dramatic increase in each of the mes- 
sages coding for the protein. There are several lines of evidence 
presented in our study strongly implying that HSF is exerting 
its  control of fibrinogen  by  regulating  transcription  of the 
three genes in an elegantly coordinated manner. Several dif- 
ferent  molecular processes could be  envisioned  for such  a 
tightly coordinated system, the simplest being the presence of 
common regulatory sites 5'  to the coding region.  Crabtree 
and Kant suggested (5) that the highly coordinated regulation 
of mRNAs for the chains of fibrinogen  may be under the 
control of a single regulatory molecule that would be inter- 
acting with sites in or around each gene. Our evidence that 
HSF brings about a coordinated increase in all three primary 
gene  products in  both  time and amount provides a  strong 
argument that HSF functions as such a molecule. Moreover, 
Fowlkes et al. (7) reported an extensive nucleotide homology 
in the 5'  flanking region of all three fibrinogen genes.  This 
finding is consistent with the hypothesis predicting a common 
regulatory  site  through  which  HSF  would  be  exerting  its 
control. 
Our data show that HSF is a critically important regulatory 
protein for fibrinogen biosynthesis. We are now investigating 
the  precise  molecular mechanism  involved  in  this  type  of 
coordinated gene regulation. 
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